Home›Companies›Biotech & Pharma›Chroma Medicine

Chroma Medicine, Inc.

Updated Oct 27, 2026·Latest SEC filing Sep 1, 2023·Suggest an edit

About Chroma Medicine

Chroma Medicine is a private company based in Boston, Massachusetts, incorporated in 2020 in Delaware. It has reported $135,000,000 raised in one offering on Form D since March 2023.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Feb 8, 2023Mar 1, 2023amended Sep 1, 2023$135,000,000fully sold21$6.4MEquityRule 506(b)Form D/A ↗1 earlier filing

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Chroma Medicine's Form D filed Sep 1, 2023.

BC
Bihua Chen
Director
KB
BK
Brett Kaplan
Chief Financial Officer
VM
Vic Myer
Executive officer
MK
CB
Catherine Stehman-Breen
Executive officer and director
PP
Paola Pozzi
Director
JM
TC

Sources

  1. SECChroma Medicine, Inc. Form D, filed Mar 1, 2023
  2. SECChroma Medicine, Inc. filing history